Selinexor, ARA-C and Idarubicin: An effective and tolerable combination in patients with relapsed, refractory AML: A multicenter phase II study

Selinexor, ARA-C and Idarubicin: An effective and tolerable combination in patients with relapsed, refractory AML: A multicenter phase II study

Learn More